Allarity Therapeutics, Inc. Common Stock
ALLR
ALLR: Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improve clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
moreShow ALLR Financials
Recent trades of ALLR by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ALLR's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on ALLR's company Twitter account
Number of mentions of ALLR in WallStreetBets Daily Discussion
Recent insights relating to ALLR
Recent picks made for ALLR stock on CNBC
ETFs with the largest estimated holdings in ALLR
Flights by private jets registered to ALLR